Title: “Complementary and Integrative Health for Cancer Related Peripheral Neuropathy”
Presenter: Ting Bao, MD
Zakim Center for Integrative Therapies and Healthy Living, Dana Farber Cancer Institute, Boston, MA
Date/Time: Tuesday, August 1st @ 8:00-9:00am US ET via Zoom.
Cost: Free. CME credit available. Please email your name, degree title and institution if applicable to [email protected] during the event to claim credit.
Chemotherapy-induced peripheral neuropathy (CIPN) is a painful, debilitating complication of neurotoxic chemotherapy that affects up to 60% of cancer patients. This condition may last from months to years, and is associated with significant pain, tingling, and numbness, as well as worsened function and quality of life (QoL). Despite growing research, management of CIPN remains a major clinical challenge. Integrative medicine refers to use non-pharmacological approaches such as acupuncture and yoga to alleviate symptoms. Integrative medicine has been used to treat a wide range of conditions experienced by cancer survivors. In this session, Dr. Bao will discuss the use of integrative medicine approaches to reduce CIPN symptoms, present their pilot trial results and introduce their ongoing clinical trials on integrative medicine and CIPN treatment.
Ting Bao, MD is the past president of Society for Integrative Oncology (SIO) and the current co-chair of SIO Education Committee. She is the Co-Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memorial Sloan Kettering Cancer Center (MSK) Integrative Medicine and Breast Medicine services and the director of Integrative Breast Oncology program at MSK from 4/2014 to 7/2023. She is a board-certified breast medical oncologist and medical acupuncturist, and integrative medicine physician. She has conducted a number of clinical trials that examine the safety, effectiveness, and underlying mechanisms of acupuncture and yoga to improve cancer patients’ quality of life and to address treatment- and disease-related symptoms. Because of her clinical and research expertise, she is a member of National Cancer Institute (NCI) Physician Data Query Complementary and Alternative Medicine (CAM) Editorial Board. She is also a member of the Alliance for Clinical Trials in Oncology Symptom Intervention Committee and she is a speaker and panelist for NCI conducted workshops on oncology acupuncture and cancer CAM.
Born and raised in Beijing, China, she received her medical education at Johns Hopkins School of Medicine, with residency at John Hopkins Bayview Medical Center and medical oncology fellowship at the Kimmel Comprehensive Cancer Center. Her Masters of Science in clinical research is from the University of Maryland. Prior to her position at Memorial Sloan Kettering, she was a joint faculty member at the University of Maryland Greenebaum Cancer Center and Center for Integrative Medicine. She is board-certified in medical oncology, internal medicine and acupuncturist.